N4 Pharma (GB:N4P) has released an update.
N4 Pharma PLC has reported a change in major holdings following a recent share placement, with Marc Mathenz acquiring a notable 8.36% voting rights, as per the 18 June 2024 notification. The company’s issued share capital has increased after the placement, with Mathenz participating in the transaction. The reporting was completed in Singapore on the date of the announcement.
For further insights into GB:N4P stock, check out TipRanks’ Stock Analysis page.
